Results 21 to 30 of about 4,695 (214)

Hemolytic disease of the fetus and newborn caused by irregular antibody: A mortality case report and case series during the past 15 years in NCKUH

open access: yesTaiwanese Journal of Obstetrics & Gynecology, 2022
Objective: Hemolytic disease of the fetus and newborn (HDFN) caused by irregular antibodies is a rare, but possibly life-threatening condition. We report a case of severe intrauterine hemolysis caused by anti-E alloimmunization, and review 16 cases in ...
Ming-Ta Chuang, Chiung-Hsin Chang
doaj   +2 more sources

Hemolytic disease of newborn following anti-C and anti-S alloimmunization: A case report with review of literature

open access: yesIndian Pediatrics Case Reports, 2023
Background: Non-Rhesus D antigen non-ABO, minor blood group alloimmunization in pregnant women is being increasingly recognized as a significant contributor to the development of the hemolytic disease of the fetus and newborn (HDFN).
Shrutiprajna Kar   +3 more
doaj   +2 more sources

AB0 Hemolytic Disease of the Newborn Development in the Child with АВ (IV) Blood Group from the Mother with 0 (I) Blood Group: Clinical Case [PDF]

open access: yesВопросы современной педиатрии, 2020
Background. Hemolytic disease of the newborn due to AB0 incompatibility typically develops when mother has 0 (I) blood group and prenatal child has А (II) or B (III).
Natalya L. Prokoptseva   +3 more
doaj   +2 more sources

AB0-incompatibility of mother and fetus: the role of anti-glycan alloantibodies in the hemolytic disease of newborns [PDF]

open access: yesМедицинская иммунология, 2021
The mother and fetus incompatibility due to Rh-factor, blood group or other blood factors can lead to hemolytic disease of the fetus and newborn (HDN). HDN is a clinical disease condition of the fetus and newborn as a result of hemolysis, when maternal ...
P. S. Obukhova   +3 more
doaj   +2 more sources

Maternal-fetal isoimmunization – a risk for the development of hemolytic disease of the newborn [PDF]

open access: yesPharmacia
Hemolytic disease of the newborn is a condition caused by maternal alloimmunization against fetal red blood cell antigens. Transplacental hemorrhage, for example, can provoke an immune response in the mother.
Maria Hristova Savcheva   +18 more
doaj   +5 more sources

Hemolytic disease of the fetus and newborn due to Rh(D) incompatibility: A preventable disease that still produces significant morbidity and mortality in children.

open access: yesPLoS ONE, 2020
In the mid-20th century, Hemolytic Disease of the Fetus and Newborn, caused by maternal alloimmunization to the Rh(D) blood group antigen expressed by fetal red blood cells (i.e., "Rh disease"), was a major cause of fetal and neonatal morbidity and ...
Valeria Pegoraro   +6 more
doaj   +2 more sources

Hemolytic disease of the fetus and newborn: A review of pathophysiology, diagnosis, and management

open access: yesBest Practice & Research Clinical Obstetrics & Gynaecology
Hemolytic Disease of the Fetus and Newborn (HDFN) results from maternal alloantibodies attacking fetal red blood cells, leading to fetal anemia and potentially severe complications such as hydrops fetalis. Effective management relies on early detection through maternal antibody screening, fetal antigen testing, and close monitoring of fetal anemia.
Hajra Malik   +2 more
openaire   +3 more sources

Five Pathogenetic Classifications for Alloimmune Hemolytic Disease of the Fetus And Newborn

open access: yesTransfusion Medicine Reviews
Maternal alloantibody-induced hemolytic disease of the fetus and newborn (HDFN) remains a significant concern worldwide. Alloimmune HDFN can be pathogenetically named by the specific alloantibodies involved. Moreover, four mechanistic pathway types are generally recognized in clinical practice: classical or extravascular hemolysis; immune-pressure ...
Hitoshi Ohto   +2 more
openaire   +3 more sources

Clinical value of different anti-D immunoglobulin strategies for preventing Rh hemolytic disease of the fetus and newborn: A network meta-analysis.

open access: yesPLoS ONE, 2020
BackgroundSeveral anti-D immunoglobulin strategies exist for preventing Rh hemolytic disease of the fetus and newborn. This study systematically assessed the clinical value of those therapeutic strategies.MethodsThe Web of Science, PubMed, EMBASE, China ...
Xiaohui Xie   +4 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy